Recent Posts

Research: Can newly-public biotech succeed at translational science? by Laura McNamee and Fred Ledley

Jan 22, 2014 by
Fred D. Ledley
Laura McNamee

Early-stage biotech companies play a critical role in the entrepreneurial ecosystem that is expected to develop commercial products from nascent scientific discoveries. Recent research from the Center for Integration of Science and Industry suggests that companies in the IPO “class of 2000” were ineffective in developing therapeutic products and asks whether the business models of newly-public biotech companies are up to the task.

Blog: Can changes in accounting for R&D promote innovation?

Nov 18, 2013 by
Fred D. Ledley
GDP figure

Recent revisions in how R&D is represented in calculating the Gross Domestic Product (GDP) added ½ trillion dollars to measures of the US economy. Fred Ledley anticipates that similar changes in accounting standards could significantly increase the recognized value of innovation on Bentley University’s IMPACT.